Autonomic and hemodynamic origins of pre-hypertension: Central role of heredity

Journal of the American College of Cardiology

Volumn 59, Issue 24, 2012, Pages 2206-2216

  Davis, Jason T ^a,b   Rao, Fangwen ^a,b   Naqshbandi, Dalal ^a,b   Fung, Maple M ^a,b   Zhang, Kuixing ^a,b   Schork, Andrew J ^a,b   Nievergelt, Caroline M ^a,b   Ziegler, Michael G ^a,b   O'Connor, Daniel T ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c San Diego   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

autonomic; genetics; hypertension; nervous system

Indexed keywords

ADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALCIUM CHANNEL VOLTAGE DEPENDENT L TYPE ALPHA 1C GENE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC VARIABILITY; GENOME ANALYSIS; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART OUTPUT MEASUREMENT; HEART RATE VARIABILITY; HEART STROKE VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MOLECULAR PATHOLOGY; NORADRENALIN RELEASE; PARASYMPATHETIC TONE; PLEIOTROPY; PREHYPERTENSION; PRIORITY JOURNAL; PULSE PRESSURE; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPATHETIC TONE;

ADULT; BLOOD PRESSURE; CALCIUM CHANNELS, L-TYPE; CARDIAC OUTPUT; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HEMODYNAMICS; HUMANS; MALE; MYOCARDIAL CONTRACTION; NOREPINEPHRINE; PREHYPERTENSION; STROKE VOLUME; VASCULAR RESISTANCE;

EID: 84861889678     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.040     Document Type: Article

References (46)

1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. (Pubitemid 37430158)
2. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of pre-hypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit 2005;11:CR403-9. (Pubitemid 41330130)
3. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-6. (Pubitemid 33124327)
4. Ogunniyi MO, Croft JB, Greenlund KJ, Giles WH, Mensah GA. Racial/ethnic differences in microalbuminuria among adults with pre-hypertension and hypertension: National Health and Nutrition Examination Survey (NHANES), 1999-2006. Am J Hypertens 2010; 23:859-64.
5. Ishikawa Y, Ishikawa J, Ishikawa S, et al. Pre-hypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study. J Hypertens 2010;28:1630-7.
6. Pletcher MJ, Bibbins-Domingo K, Lewis CE, et al. Pre-hypertension during young adulthood and coronary calcium later in life. Ann Intern Med 2008;149:91-9. (Pubitemid 352035334)
7. Lorenzo C, Aung K, Stern MP, Haffner SM. Pulse pressure, prehypertension, and mortality: the San Antonio heart study. Am J Hypertens 2009;22:1219-26.
8. Rao F, Wessel J, Wen G, et al. Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. Hypertension 2007;49:1015-31. (Pubitemid 351664306)
9. Brinton TJ, Cotter B, Kailasam MT, et al. Development and validation of a noninvasive method to determine arterial pressure and vascular compliance. Am J Cardiol 1997;80:323-30. (Pubitemid 27330149)
10. Chio SS, Tsai JJ, Hsu YM, et al. Development and validation of a noninvasive method to estimate cardiac output using cuff sphygmomanometry. Clin Cardiol 2007;30:615-20. (Pubitemid 350293342)
11. Chio SS, Urbina EM, Lapointe J, Tsai J, Berenson GS. Korotkoff sound versus oscillometric cuff sphygmomanometers: comparison between auscultatory and DynaPulse blood pressure measurements. J Am Soc Hypertens 2011;5:12-20.
12. Kennedy B, Ziegler MG. A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci 1990;47:2143-53.
13. Toichi M, Sugiura T, Murai T, Sengoku A. A new method of assessing cardiac autonomic function and its comparison with spectral analysis and coefficient of variation of R-R interval. J Auton Nerv Syst 1997;62:79-84. (Pubitemid 27043087)
14. Dev NB, Gayen JR, O'Connor DT, Mahata SK. Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment. Endocrinology 2010;151:2760-8.
15. Zhang L, Rao F, Wessel J, et al. Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins. Physiol Genomics 2004;19:277-91. (Pubitemid 40039934)
16. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-211. (Pubitemid 28199022)
17. Wood DL, Sheps SG, Elveback LR, Schirger A. Cold pressor test as a predictor of hypertension. Hypertension 1984;6:301-6. (Pubitemid 14091456)
18. Bremer T, Man A, Kask K, Diamond C. CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension. Pharmacogenomics 2006;7:271-9.
19. The International Hapmap Project. Available at: www.hapmap.org. Accessed May 21, 2012.
20. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet 2002;3:872-82. (Pubitemid 35303519)
21. Rao F, Zhang L, Wessel J, et al. Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 2007;116:993-1006. (Pubitemid 47329564)
22. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009;41:677-87.
23. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009;41:666-76.
24. Shih PA, O'Connor DT. Hereditary determinants of human hypertension: strategies in the setting of genetic complexity. Hypertension 2008;51:1456-64.
25. Zhang K, Weder AB, Eskin E, O'Connor DT. Genome-wide case/control studies in hypertension: only the 'tip of the iceberg.' J Hypertens 2010;28:1115-23.
26. Zhao Y, Zhai D, He H, Li T, Chen X, Ji H. Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort. Eur J Clin Pharmacol 2009;65:579-84.
27. Johnson AD, Newton-Cheh C, Chasman DI, et al. Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals. Hypertension 2011;57:903-10.
28. Beitelshees AL, Navare H, Wang D, et al. CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response. Circ Cardiovasc Genet 2009;2:362-70.
29. Esler M, Rumantir M, Kaye D, Lambert G. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? Am J Hypertens 2001;14:139S-46S. (Pubitemid 32506708)
30. Jacobs MC, Lenders JW, Willemsen JJ, Thien T. Adrenomedullary secretion of epinephrine is increased in mild essential hypertension. Hypertension 1997;29:1303-8. (Pubitemid 27233181)
31. Palatini P, Julius S. The role of cardiac autonomic function in hypertension and cardiovascular disease. Curr Hypertens Rep 2009; 11:199-205.
32. Rahn KH, Barenbrock M, Hausberg M. The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens 1999;17 Suppl:S11- 4.
33. Tycinska AM, Mroczko B, Musial WJ, et al. Blood pressure in relation to neurogenic, inflammatory and endothelial dysfunction biomarkers in patients with treated essential arterial hypertension. Adv Med Sci 2011;56:80-7.
34. Lake CR, Ziegler MG, Coleman MD, Kopin IJ. Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med 1977;296:208-9. (Pubitemid 8031211)
35. Beretta-Piccoli C, Bianchetti MG, Pusterla C, Weidmann P. Cardiovascular hypersensitivity to norepinephrine in normotensive members of hypertensive families: influence of dietary sodium and potassium intake. Bibl Cardiol 1987:144-51.
36. Zhu H, Yan W, Ge D, et al. Cardiovascular characteristics in American youth with pre-hypertension. Am J Hypertens 2007;20: 1051-7. (Pubitemid 47446172)
37. Drukteinis JS, Roman MJ, Fabsitz RR, et al. Cardiac and systemic hemodynamic characteristics of hypertension and pre-hypertension in adolescents and young adults: the Strong Heart Study. Circulation 2007;115:221-7. (Pubitemid 46105721)
38. Dart AM, Kingwell BA. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001;37:975-84. (Pubitemid 32217593)
39. Lund-Johansen P. Central haemodynamics in essential hypertension. Acta Med Scand 1977;606 Suppl:35-42. (Pubitemid 8177084)
40. Li C, Li Y, Wang X, Zhang S, Ning G, Zheng X. Cardiac dysfunction investigation in pre-hypertension. Conf Proc IEEE Eng Med Biol Soc 2005;7:7628-31.
41. Fung MM, Rao F, Poddar S, et al. Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects. Am J Hypertens 2011;24:225-33.
42. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006;354:1685-97.
43. Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a metaanalysis. JAMA 2011;305:913-22.
44. Svetkey LP. Management of pre-hypertension. Hypertension 2005; 45:1056-61.
45. Vollmer WM, Sacks FM, Ard J, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001;135:1019-28. (Pubitemid 33151023)
46. Keller S, Frishman WH. Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev 2003;11:73-93. (Pubitemid 36363121)